Evidence-Based Complementary and Alternative Medicine

Traditional Chinese Medicine for Digestive System Tumors


Publishing date
01 Dec 2022
Status
Published
Submission deadline
12 Aug 2022

Lead Editor

1First Affiliated Hospital of Hebei North University, Zhangjiakou, China

2Sun Yat-sen University, Guangzhou, China

3University of California, San Francisco, USA


Traditional Chinese Medicine for Digestive System Tumors

Description

Digestive system tumors, including esophageal cancer, gastric cancer, and colorectal cancer, are among the most common cancer types in the world and are the cause of much cancer-related mortality in the world. They are a major threat to human health and are usually diagnosed at an advanced stage. A large number of studies have investigated the use of traditional Chinese medicine (TCM) as an adjuvant therapy in the treatment of digestive system tumors. This TCM has been suggested to possess great advantages in terms of suppressing tumor progression, increasing the sensitivity of chemo-, radio-, or targeted therapeutics, improving an organism's immune system function, and lessening the damage caused by these therapeutics.

In recent years, anti-tumor preparation of TCM has become a hot spot in the research and development of new drugs. Before components and compounds derived from TCM can enter clinical trials of new drugs, there must be research into their pharmacodynamics and safety and evidence to support their preclinical effectiveness. In order to improve the medicinal properties of these TCM drugs, it is urgent to strengthen research on the correlation between their antitumor activity and cytotoxic effect in the digestive system. There also needs to be research directed towards new drug delivery technologies, methods, and advantages of improving oral absorption, changing distribution in vivo, and increasing targeting and improving percutaneous and mucosal absorption of TCM active ingredients. Intestinal flora is a complex microecosystem in the human body, known as the second genome of the human body. TCM can play an anti-tumor role by regulating intestinal flora in coordination with anti-cancer drugs, increasing body immunity, inhibiting the expression of inflammatory factors, and promoting the activity of probiotics.

The aim of this Special Issue is to collect original and review articles on basic and clinical research discussing TCM and natural products for gastrointestinal tract cancer prevention and therapy. We especially welcome applications of TCM and natural products in enhancing chemotherapy and immunotherapy.

Potential topics include but are not limited to the following:

  • Isolation and characterization of natural products with anti-digestive system tumor activity
  • Chemical properties, structure identification, and synthetic routes of natural and herbal extracts
  • Toxicological effects of natural and herbal extracts with anti-digestive system tumor activity
  • Biological and pharmacological activities of natural and herbal extracts in the prevention and treatment of digestive system tumors.
  • Research on the medicinal properties of natural and herbal extracts, including efficacy, safety, pharmacokinetics, absorption, distribution, and excretion pathways in vivo
  • Synergistic effect of drugs and natural products on digestive system tumors
  • Preclinical and clinical trials of natural and herbal extracts for the treatment of digestive system tumors
  • Bioinformatics analysis of natural and herbal extracts for the treatment of digestive system tumors
  • The effect of intestinal flora on tumors and the regulating effect of Chinese medicine on intestinal flora
  • Effects of intestinal flora on tumor immunity and the effects of the intervention of TCM

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 1092107
  • - Research Article

Knockdown of Long Noncoding RNA 01124 Inhibits the Malignant Behaviors of Colon Cancer Cells via miR-654-5p/HAX-1

Yu-jin Wu | Zhi-quan Cai | ... | Fang-hua Qiu
  • Special Issue
  • - Volume 2022
  • - Article ID 9616582
  • - Research Article

[Retracted] High-Throughput Sequencing Investigation of Bacterial Diversity in Chronic Suppurative Otitis Media and Middle Ear Cholesteatoma

Xiuqin Cheng | Abulajiang Tuoheti | ... | Xingzhi Gu
  • Special Issue
  • - Volume 2022
  • - Article ID 4731675
  • - Research Article

Skin Commensal Bacteria Modulates the Immune Balance of Mice to Alleviate Atopic Dermatitis-Induced Damage

Xianshui Yu | Ting Chen | ... | Ling Yang
  • Special Issue
  • - Volume 2022
  • - Article ID 3512582
  • - Research Article

Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019

Guoliang Liu | Mingzhao Qin
  • Special Issue
  • - Volume 2022
  • - Article ID 9779951
  • - Research Article

[Retracted] The Change of Aqueous Humor Cytokine Levels after Anti-VEGF in Diabetic Macular Edema: A Systematic Review and Meta-Analysis

Aoxiang Wang | Haiyan Wang
  • Special Issue
  • - Volume 2022
  • - Article ID 6225282
  • - Research Article

[Retracted] Surfactant without Endotracheal Tube Intubation (SurE) versus Intubation-Surfactant-Extubation (InSurE) in Neonatal Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis

Lirong Wang | Min Zhang | Qingfeng Yi
  • Special Issue
  • - Volume 2022
  • - Article ID 2075638
  • - Research Article

A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma

Lan Luo | Xiaoyan Hu | ... | Ming Li
  • Special Issue
  • - Volume 2022
  • - Article ID 7332337
  • - Research Article

HBV Promotes the Proliferation of Liver Cancer Cells through the hsa_circ_0000847/miR-135a Pathway

Jianjun Lin | Xiang Lian | ... | Longteng Xie
  • Special Issue
  • - Volume 2022
  • - Article ID 6880974
  • - Research Article

Aberrant Expression of SIRT6 and VNN1 in Peripheral Blood Monocytes of Children with Primary Nephrotic Syndrome and Its Diagnostic and Prognostic Values

Peitong Han | Xiaohong Xi | ... | Jieyuan Cui
  • Special Issue
  • - Volume 2022
  • - Article ID 6913315
  • - Research Article

The Predictive Values of MMP-9, PLTs, ESR, and CRP Levels in Kawasaki Disease with Cardiovascular Injury

Yinan Yang | Xiaobin Hu

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.